Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
Molina, Jean-Michel, Dr, Prof, Cahn, Pedro, MD, Grinsztejn, Beatriz, MD, Lazzarin, Adriano, Prof, Mills, Anthony, MD, Saag, Michael, Prof, Supparatpinyo, Khuanchai, Prof, Walmsley, Sharon, Prof, Crauwels, Herta, PhD, Rimsky, Laurence T, PhD, Vanveggel, Simon, MSc, Boven, Katia, MD
Published in The Lancet (British edition) (16.07.2011)
Published in The Lancet (British edition) (16.07.2011)
Get full text
Journal Article
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Cohen, Calvin J, Dr, Andrade-Villanueva, Jaime, Prof, Clotet, Bonaventura, MD, Fourie, Jan, MD, Johnson, Margaret A, Prof, Ruxrungtham, Kiat, Prof, Wu, Hao, MD, Zorrilla, Carmen, MD, Crauwels, Herta, PhD, Rimsky, Laurence T, PhD, Vanveggel, Simon, MSc, Boven, Katia, MD
Published in The Lancet (British edition) (16.07.2011)
Published in The Lancet (British edition) (16.07.2011)
Get full text
Journal Article